BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 17681956)

  • 1. The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography.
    Tahara N; Kai H; Nakaura H; Mizoguchi M; Ishibashi M; Kaida H; Baba K; Hayabuchi N; Imaizumi T
    Eur Heart J; 2007 Sep; 28(18):2243-8. PubMed ID: 17681956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome.
    Tahara N; Kai H; Yamagishi S; Mizoguchi M; Nakaura H; Ishibashi M; Kaida H; Baba K; Hayabuchi N; Imaizumi T
    J Am Coll Cardiol; 2007 Apr; 49(14):1533-9. PubMed ID: 17418291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
    Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G
    Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
    Rudd JH; Myers KS; Bansilal S; Machac J; Pinto CA; Tong C; Rafique A; Hargeaves R; Farkouh M; Fuster V; Fayad ZA
    J Nucl Med; 2008 Jun; 49(6):871-8. PubMed ID: 18483100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.
    Tawakol A; Migrino RQ; Bashian GG; Bedri S; Vermylen D; Cury RC; Yates D; LaMuraglia GM; Furie K; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
    J Am Coll Cardiol; 2006 Nov; 48(9):1818-24. PubMed ID: 17084256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thresholds for Arterial Wall Inflammation Quantified by
    van der Valk FM; Verweij SL; Zwinderman KA; Strang AC; Kaiser Y; Marquering HA; Nederveen AJ; Stroes ES; Verberne HJ; Rudd JH
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1198-1207. PubMed ID: 27639759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High resolution FDG-microPET of carotid atherosclerosis: plaque components underlying enhanced FDG uptake.
    Liu J; Kerwin WS; Caldwell JH; Ferguson MS; Hippe DS; Alessio AM; Martinez-Malo V; Pimentel K; Miyaoka RS; Kohler TR; Hatsukami TS; Yuan C
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):145-52. PubMed ID: 26280889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.
    Rudd JH; Myers KS; Bansilal S; Machac J; Rafique A; Farkouh M; Fuster V; Fayad ZA
    J Am Coll Cardiol; 2007 Aug; 50(9):892-6. PubMed ID: 17719477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between nonalcoholic fatty liver disease and carotid artery inflammation evaluated by 18F-fluorodeoxyglucose positron emission tomography.
    Moon SH; Noh TS; Cho YS; Hong SP; Hyun SH; Choi JY; Kim BT; Lee KH
    Angiology; 2015 May; 66(5):472-80. PubMed ID: 24904182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
    Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K
    Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
    Huet P; Burg S; Le Guludec D; Hyafil F; Buvat I
    J Nucl Med; 2015 Apr; 56(4):552-9. PubMed ID: 25722452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods.
    Izquierdo-Garcia D; Davies JR; Graves MJ; Rudd JH; Gillard JH; Weissberg PL; Fryer TD; Warburton EA
    Stroke; 2009 Jan; 40(1):86-93. PubMed ID: 18927453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake.
    Bucerius J; Mani V; Moncrieff C; Rudd JH; Machac J; Fuster V; Farkouh ME; Fayad ZA
    J Am Coll Cardiol; 2012 Jun; 59(23):2080-8. PubMed ID: 22651864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18FDG PET and ultrasound echolucency in carotid artery plaques.
    Graebe M; Pedersen SF; Højgaard L; Kjaer A; Sillesen H
    JACC Cardiovasc Imaging; 2010 Mar; 3(3):289-95. PubMed ID: 20223427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography measurement of periodontal 18F-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation.
    Fifer KM; Qadir S; Subramanian S; Vijayakumar J; Figueroa AL; Truong QA; Hoffmann U; Brady TJ; Tawakol A
    J Am Coll Cardiol; 2011 Feb; 57(8):971-6. PubMed ID: 21329844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography.
    Kim TN; Kim S; Yang SJ; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Circ Cardiovasc Imaging; 2010 Mar; 3(2):142-8. PubMed ID: 20061516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carotid inflammation on ¹⁸F-fluorodeoxyglucose positron emission tomography associates with recurrent ischemic lesions.
    Kim HJ; Oh M; Moon DH; Yu KH; Kwon SU; Kim JS; Kang DW
    J Neurol Sci; 2014 Dec; 347(1-2):242-5. PubMed ID: 25454641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system.
    Li X; Heber D; Rausch I; Beitzke D; Mayerhoefer ME; Rasul S; Kreissl M; Mitthauser M; Wadsak W; Hartenbach M; Haug A; Zhang X; Loewe C; Beyer T; Hacker M
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1503-12. PubMed ID: 26816195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial.
    Potter K; Lenzo N; Eikelboom JW; Arnolda LF; Beer C; Hankey GJ
    Cerebrovasc Dis; 2009; 27(3):259-65. PubMed ID: 19202330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.